Latest Ratios: P/E Ratio 16.1x · EV/EBITDA 11.5x · ROE 13.8%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.8B | $3.6B | $3.9B | $3.3B | $2.9B | $2.4B | $1.9B | $2.1B | $1.7B | $1.7B | $1.5B |
| Enterprise Value | $3.7B | $3.5B | $472M | $952M | $-133914980 | $387M | $360M | $241M | $272M | $-59162800 | $-337277810 |
| P/E Ratio → | 16.06 | 14.89 | 18.20 | 15.35 | 15.28 | 14.03 | 19.57 | 15.42 | 13.27 | 19.30 | 20.96 |
| P/S Ratio | 4.66 | 4.36 | 4.33 | 4.03 | 4.89 | 4.73 | 4.20 | 4.39 | 3.89 | 4.55 | 4.55 |
| P/B Ratio | 2.09 | 1.94 | 2.43 | 2.27 | 2.36 | 2.01 | 1.83 | 2.07 | 1.85 | 2.15 | 2.08 |
| P/FCF | 16.20 | 15.17 | 17.54 | 15.48 | 14.28 | 13.30 | 22.05 | 15.78 | 18.93 | 18.16 | 18.58 |
| P/OCF | 13.46 | 12.60 | 15.08 | 13.99 | 13.03 | 11.53 | 12.59 | 13.09 | 11.91 | 15.18 | 16.35 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.25 | 0.52 | 1.18 | -0.22 | 0.78 | 0.78 | 0.51 | 0.64 | -0.16 | -1.04 |
| EV / EBITDA | 11.49 | 10.74 | 1.59 | 3.26 | -0.52 | 1.69 | 2.54 | 1.30 | 1.57 | -0.40 | -2.80 |
| EV / EBIT | 12.35 | 11.54 | 1.71 | 3.53 | -0.56 | 1.86 | 2.92 | 1.42 | 1.71 | -0.43 | -3.12 |
| EV / FCF | — | 14.78 | 2.10 | 4.52 | -0.65 | 2.19 | 4.08 | 1.83 | 3.09 | -0.64 | -4.23 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.9% | 82.9% | 68.5% | 74.4% | 90.7% | 99.5% | 82.1% | 86.7% | 89.1% | 92.0% | 91.9% |
| Operating Margin | 36.8% | 36.8% | 30.3% | 33.4% | 39.3% | 41.9% | 26.6% | 35.8% | 37.3% | 37.2% | 33.2% |
| Net Profit Margin | 29.2% | 29.2% | 23.8% | 26.3% | 32.0% | 33.7% | 21.4% | 28.5% | 29.4% | 23.6% | 21.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 13.8% | 13.8% | 14.2% | 15.8% | 15.9% | 15.0% | 9.6% | 14.1% | 15.0% | 11.6% | 10.3% |
| ROA | 1.7% | 1.7% | 1.7% | 1.7% | 1.8% | 1.8% | 1.1% | 1.7% | 1.7% | 1.2% | 1.0% |
| ROIC | 12.3% | 12.3% | 12.8% | 14.2% | 13.7% | 13.3% | 8.7% | 12.9% | 13.8% | 13.2% | 11.3% |
| ROCE | 3.6% | 3.6% | 15.7% | 18.0% | 18.3% | 17.7% | 11.6% | 17.3% | 18.4% | 17.6% | 15.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.07 | 0.07 | 0.05 | 0.06 | 0.07 | 0.07 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 |
| Debt / EBITDA | 0.41 | 0.41 | 0.29 | 0.31 | 0.33 | 0.38 | 0.20 | 0.15 | 0.16 | 0.22 | 0.27 |
| Net Debt / Equity | — | -0.05 | -2.14 | -1.61 | -2.46 | -1.68 | -1.49 | -1.83 | -1.55 | -2.22 | -2.56 |
| Net Debt / EBITDA | -0.29 | -0.29 | -11.68 | -7.90 | -11.88 | -8.60 | -11.20 | -9.92 | -8.05 | -11.65 | -15.11 |
| Debt / FCF | — | -0.39 | -15.44 | -10.96 | -14.93 | -11.12 | -17.97 | -13.95 | -15.83 | -18.80 | -22.81 |
| Interest Coverage | 0.98 | 0.98 | 0.99 | 1.35 | 5.15 | 18.34 | 6.04 | 3.10 | 3.74 | 6.51 | 7.32 |
Net cash position: cash ($227M) exceeds total debt ($134M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.32 | 20.32 | 0.33 | 0.37 | 0.45 | 0.35 | 0.29 | 0.34 | 0.36 | 0.37 | 0.39 |
| Quick Ratio | 20.32 | 20.32 | 0.33 | 0.37 | 0.45 | 0.35 | 0.29 | 0.34 | 0.36 | 0.37 | 0.39 |
| Cash Ratio | 17.16 | 17.16 | 0.30 | 0.22 | 0.29 | 0.25 | 0.20 | 0.25 | 0.21 | 0.27 | 0.29 |
| Asset Turnover | — | 0.06 | 0.07 | 0.07 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.6% | 1.7% | 1.5% | 1.6% | 1.6% | 1.9% | 2.2% | 1.9% | 1.8% | 1.5% | 1.5% |
| Payout Ratio | 25.9% | 25.9% | 26.7% | 25.2% | 25.1% | 26.9% | 42.6% | 29.5% | 24.1% | 28.7% | 32.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.2% | 6.7% | 5.5% | 6.5% | 6.5% | 7.1% | 5.1% | 6.5% | 7.5% | 5.2% | 4.8% |
| FCF Yield | 6.2% | 6.6% | 5.7% | 6.5% | 7.0% | 7.5% | 4.5% | 6.3% | 5.3% | 5.5% | 5.4% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.5% | 0.2% | 0.1% | 0.5% | 0.0% | 0.4% |
| Total Shareholder Yield | 1.6% | 1.7% | 1.5% | 1.7% | 1.6% | 2.4% | 2.3% | 2.0% | 2.3% | 1.5% | 1.9% |
| Shares Outstanding | — | $34M | $34M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $32M |
Geographic and sector concentration
With a P/B ratio of 2.10, BancFirst trades at a significant premium to peers like Simmons First National, suggesting that investors are pricing in the durability of its Oklahoma deposit franchise rather than just the current, somewhat muted, return on tangible equity metrics.
The elevated P/B multiple appears to reflect market confidence in the bank's unique role as a municipal bond trustee and its localized rural dominance. However, investors should monitor whether this premium is sustainable if the current revenue contraction persists or if the Dallas expansion fails to deliver accretive returns relative to the core Oklahoma business.
Based on quarterly data, BancFirst's ROE has remained range-bound between 3.3% and 3.8% over the last ten quarters, a figure that appears artificially suppressed by the bank's exceptionally conservative capital structure and high equity-to-assets ratio of 0.13.
The DuPont decomposition suggests that while the bank maintains a stable NIM, the lack of leverage significantly drags down the headline ROE. This indicates that the bank's profitability is driven more by balance sheet safety than by aggressive asset utilization, which may limit upside for shareholders seeking higher capital efficiency.
As reported in recent financial statements, the net interest margin has hovered between 0.8% and 0.9% for most of the last ten quarters, indicating that the bank's core spread management is currently facing structural headwinds from rising deposit costs in its core markets.
The efficiency ratio, which spiked to 59.3% in 2025Q4 before normalizing to 38.8% in 2026Q1, suggests that management retains the ability to control operating costs despite the lumpiness of acquisition-related expenses. Investors should monitor whether the bank can maintain this discipline if competitive pressures in the Dallas market force a higher deposit beta.
According to recent regulatory filings, the bank's equity-to-assets ratio of 0.13 and minimal debt-to-equity ratio of 0.07 indicate a fortress balance sheet that provides substantial protection against credit volatility but may be underutilized in terms of driving long-term shareholder value.
This capital position suggests that the bank is well-positioned to weather regional economic downturns or pursue further bolt-on acquisitions without needing external financing. However, the lack of leverage warrants further investigation into whether management is being overly cautious, potentially sacrificing higher returns on equity for an unnecessary level of safety.
The P/E ratio is frequently misapplied to BancFirst because it fails to account for the extreme volatility in provision expenses, such as the $107.4 million negative provision in 2025Q4, which significantly distorts earnings and obscures the underlying operational performance of the bank.
Investors should prioritize P/TBV and normalized ROE over P/E, as the latter is highly sensitive to CECL-driven accounting adjustments that do not reflect cash-generative capacity. Relying on P/E may lead to incorrect conclusions about the bank's valuation during periods of significant provisioning swings.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BANF stock.
BancFirst Corporation's current P/E ratio is 16.1x. The historical average is 15.2x. This places it at the 73th percentile of its historical range.
BancFirst Corporation's current EV/EBITDA is 11.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 5.0x.
BancFirst Corporation's return on equity (ROE) is 13.8%. The historical average is 12.9%.
Based on historical data, BancFirst Corporation is trading at a P/E of 16.1x. This is at the 73th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
BancFirst Corporation's current dividend yield is 1.60% with a payout ratio of 25.9%.
BancFirst Corporation has 82.9% gross margin and 36.8% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
BancFirst Corporation's Debt/EBITDA ratio is 0.4x, indicating low leverage. A ratio below 2x is generally considered financially healthy.